Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

Recent advances in RAS-targeted therapies revolutionize treatment for gastrointestinal cancers, promising improved outcomes ...

Jenna Scott said doctors chalked up her abdominal cramping to pregnancy symptoms or IBS. It took a year to get diagnosed with ...

Appendix cancer is rare but it can still affect anyone The key is to stay vigilant watch out for early signs and take ...

BE is the only known precursor to esophageal cancer. The condition is caused by prolonged exposure of the esophagus to ...

Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the ...

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal ...

A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

There is currently a trial at the National Institutes of Health involving a revolutionary new treatment for cancer called Tumor-Infiltrating Immunotherapy. It uses one’s own immune cells to fight ...

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

New combination therapy of relacorilant and nab-paclitaxel shows promise in extending survival for patients with ...